Elite Research Centers Ink Deal with Lonza to Evaluate (Pilot) Cell Therapy Manufacturing for Next Generation Treatments

Elite Research Centers Ink Deal with Lonza to Evaluate (Pilot) Cell Therapy Manufacturing for Next Generation Treatments

In a notable partnership, Switzerland-based Lonza inked a partnership with leading research institutes and academic medical centers including Stanford University School of Medicine, Fred Hutchinson Cancer Research Center and Parker Institute for Cancer Immunotherapy on pioneering autologous cell therapy research and process development projects. Lonza will collaborate with each partner to tech transfer several of their respective cell therapy manufacturing processes into the automated Cocoon® Platform and exhibit the technology’s ability to manufacture in a decentralized model. The partnership, while moving to a more scalable model for cell therapy manufacturing, acknowledges the crucial role research institutes and academic clinical centers fill in developing next-generation cell therapies, such as early-phase clinical cell therapy manufacturing, aims to streamline development timelines, advancing therapies to the clinic faster and make treatment available to more patients.

These premier institutions are leaders in cell-based immunotherapy discovery and development and hence notable news they have elected to collectively partner with Lonza to opt for the use of the Cocoon® Pla...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee